Results 121 to 130 of about 12,958 (242)

The phenomenology of psychedelic experiences

, 2023
Over the past couple of decades, empirical research into the clinical and therapeutic application of psychedelic drugs has shown great promise in treating a wide range of psychiatric conditions.
Forde, Danny
core  

ACUTE BEHAVIORAL EFFECTS AND PHARMACOKINETIC PROFILE OF METHOXPHENIDINE IN WISTAR RATS.

IBRO Neuroscience Reports, 2023
Kristýna Mazochová, Klára Šíchová, Eva Lhotková, Tomáš Páleníček   +3 more
doaj   +1 more source

Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality

Psychopharmacology
Rationale. Anecdotal evidence suggests that psychedelic researchers often have personal experiences with psychedelic substances. While such experiences may benefit research, concerns have been raised about potential biases and “excessive enthusiasm.” However, the prevalence of personal experiences, their perceived relevance, and their association with ...
Jussi Jylkkä, Aila Mustamo
openaire   +3 more sources

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies

Frontiers in Psychology
IntroductionPsychedelics, such as psilocybin, are increasingly recognized for their propensity to elicit powerful subjective experiences that carry personal meaning.
William Roseby, Hannes Kettner, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzoe, David J. Nutt, Robin L. Carhart-Harris, Robin L. Carhart-Harris   +11 more
doaj   +1 more source

Demoralization and Associated Factors in Palliative Oncology Outpatients: A Cross‐Sectional Study

Psycho-Oncology, Volume 35, Issue 6, June 2026.
ABSTRACT Background Demoralization is common in palliative psycho‐oncology settings. Although its relationship with other psycho‐existential conditions has been scrutinized, its co‐occurrence with adjustment disorder, as measured by the Adjustment Disorder New Module‐20 (ADNM‐20), remains unexamined.
Michael Ljuslin, Vasileios Chytas, Marie‐Estelle Gaignard, Daniel Gorman, Kate Lally, Emanuele Mazzola, Kabir Nigam, Sholevar Roxanne, Zachary Sager, Miryam Yusufov, Sophie Pautex, James Aaron Tulsky, Yvan Beaussant   +12 more
wiley   +1 more source

Human brain changes after first psilocybin use

Nature Communications
Psychedelics have robust effects on acute brain function and long-term behavior but whether they also cause enduring functional and anatomical brain changes is largely unknown.
T. Lyons, M. Spriggs, L. Kerkelä, F. E. Rosas, L. Roseman, P. A. M. Mediano, C. Timmermann, L. Oestreich, B. A. Pagni, R. J. Zeifman, A. Hampshire, W. Trender, H. M. Douglass, M. Girn, K. Godfrey, H. Kettner, F. Sharif, L. Espasiano, A. Gazzaley, M. B. Wall, D. Erritzoe, D. J. Nutt, R. L. Carhart-Harris   +22 more
doaj   +1 more source

Recreational Drug Use Amongst Children and Adolescents Presenting to Australian Emergency Departments With Acute Behavioural Disturbance: A Secondary Analysis of a Randomised Controlled Trial

Emergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objectives To describe the historical and current use of recreational drugs by a trial cohort of youth presenting to the emergency department (ED) whilst experiencing acute behavioural disturbance (ABD). Methods This was a secondary analysis of a randomised, controlled trial comparing medication management of ABD in children and adolescents ...
Elyssia M. Bourke, Kate Klein, Chris J. Selman, Katherine J. Lee, Amit Kochar, Deborah Shellshear, Meredith L. Borland, Shane George, Shefali Jani, Doris Tham, Michael Gordon, Chidambaram Prakash, Andrew Davidson, Catherine L. Wilson, Natalie Phillips, Gaby Nieva, Jonathan C. Knott, Franz E. Babl, Simon S. Craig, on behalf of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network, Hanan ElGharib, Lauren Page, Vivian Truong, Naomi Loftus, Danielle Kallianiotis, Amy Carle, Amanda Williams, Bojana Gladanac, Sharon O'Brien, Patricia Clifford, Melissa O'Brien Smith, Anne‐Maree O'Regan, Lisa Properjohn, Katy Whitten, Catherine Power, Gaby Nieva, Simone Hughes, Lara Caruso, Katie Northcott, Natalie Phillips, Angus Jones, Anne Hinde, Amy Coulson, Nadia Schmidt, Jessica Waghorn, Marietta John‐White, Riku Haataja, Zachary Wilder, Deepali Thosar, Areeba Athar, Stuart Dalziel, Thomas Sullivan, Gerben Keijzers, Stephen Hearps, Marian Chandler, Kathleen Alleaume‐Ross, Jodie Miers, M. D. Kabir, Diana Mercuri   +58 more
wiley   +1 more source

Feel connected to create: Self-reported psychedelic drug users exhibit higher sense of connectedness and better divergent thinking skills compared to non-users.

PLoS ONE
Psychedelic drugs can increase health, wellbeing, and even boost cognitive functions such as creativity. Beyond this, previous studies indicated that psychedelic drug intake can increase the sense of connectedness to the world, to others, and to the self.
Christian Rominger, Carolina Subow
doaj   +1 more source

Neotrance and the Psychedelic Festival

Dancecult, 2009
This article explores the religio-spiritual characteristics of psytrance (psychedelic trance), attending specifically to the characteristics of what I call neotrance apparent within the contemporary trance event, the countercultural inheritance of the “tribal” psytrance festival, and the dramatizing of participants’ “ultimate concerns” within the ...
openaire   +4 more sources

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source